» Authors » Camilla Di Nunzio

Camilla Di Nunzio

Explore the profile of Camilla Di Nunzio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 168
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Citterio C, Biasini C, Di Nunzio C, Lo Cascio G, Cavanna L
Vaccines (Basel) . 2024 Jan; 12(1). PMID: 38250889
Only a few studies have been carried out on the efficacy and safety of a fourth dose of the COVID-19 vaccine in patients with cancer. In this prospective observational study,...
2.
Muscaritoli M, Modena A, Valerio M, Marchetti P, Magarotto R, Quadrini S, et al.
Cancers (Basel) . 2023 Jun; 15(12). PMID: 37370816
Malnutrition affects up to 75% of cancer patients and results from a combination of anorexia and metabolic dysregulation. Metabolic and nutritional abnormalities in cancer patients can lead to cachexia, a...
3.
Cavanna L, Grassi S, Ruffini L, Michieletti E, Carella E, Palli D, et al.
Medicina (Kaunas) . 2023 Jan; 59(1). PMID: 36676781
We report on a 66-year-old man who presented with a right axillary lymphadenopathy approximately 10 days after receiving the third dose of the BNT162b2 vaccine. The lymphadenopathy gradually enlarged, and...
4.
Cavanna L, Citterio C, Di Nunzio C, Zaffignani E, Cremona G, Vecchia S, et al.
Recenti Prog Med . 2021 Dec; 112(12):785-791. PMID: 34924573
Introduction: The natural history of cancer has radically changed in the last decade. The burden of travel from patient's residence to health care providers is an important issue that can...
5.
Negrati M, Razza C, Biasini C, Di Nunzio C, Vancini A, DallAsta M, et al.
Nutrients . 2021 Oct; 13(10). PMID: 34684483
Breast cancer (BC) is a major public health concern and substantial research has shown that adhering to a healthy dietary pattern, such as the Mediterranean Diet (MD), may prevent the...
6.
Cavanna L, Cremona G, Citterio C, Di Nunzio C, Muroni M, Andena A, et al.
Tohoku J Exp Med . 2021 Sep; 255(1):61-69. PMID: 34588347
North Italy emerged as an epicenter of COVID-19 in the Western world. The majority of studies of patients with COVID-19 have focused on hospitalized patients, and data on early outpatient...
7.
Cavanna L, Citterio C, Di Nunzio C, Biasini C, Palladino M, Ambroggi M, et al.
Cureus . 2021 Apr; 13(3):e13774. PMID: 33842150
Background Cancer patients are presumed a frail group at high risk to contract coronavirus disease (COVID-19). The aim of this study was to investigate the prevalence of SARS-CoV-2 (severe acute...
8.
Cavanna L, Citterio C, Toscani I, Franco C, Magnacavallo A, Caprioli S, et al.
Future Sci OA . 2021 Jan; 7(1):FSO645. PMID: 33432270
Background: Cancer patients are considered a highly fragile group in the current coronavirus disease 2019 (COVID-19) pandemic. Material & Methods: In this study, patients with COVID-19 and cancer, hospitalized in...
9.
Porzio R, Cordini C, Maria Rodolfi A, Brigati F, Ubiali A, Proietto M, et al.
Oncol Lett . 2020 Mar; 19(3):2522-2526. PMID: 32194754
Endometrial cancer (EC) represents the most frequently occuring gynecological tumor worldwide. The aim of the present study was to estimate the prognostic value of triple negative phenotype (TNP) in EC,...
10.
Cavanna L, Stroppa E, Citterio C, Mordenti P, Di Nunzio C, Peveri S, et al.
Onco Targets Ther . 2019 May; 12:3077-3085. PMID: 31118666
Metastatic pancreatic adenocarcinoma has a very poor prognosis. Although irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX) significantly increases survival in advanced pancreatic cancer, compared to employing only gemcitabine (GEM), toxicities have...